Refuge Biotechnologies is a provider of gene engineering technologies intended to develop therapeutic cells to fight cancer. The Company connects cell membrane receptors to CRISPR a/i systems, creating a genetically programmable switch that can control multiple gene expressions, enabling healthcare professionals to accurately activate or repress gene expression.